The reality of cancer treatment in a developing country: the effects of delayed TKI treatment on survival, cytogenetic and molecular responses in chronic myeloid leukaemia patients. [electronic resource]
Producer: 20160601Description: 420-7 p. digitalISSN:- 1365-2141
- Aged
- Antineoplastic Agents -- administration & dosage
- Bosnia and Herzegovina
- Developing Countries
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fusion Proteins, bcr-abl -- genetics
- Humans
- Imatinib Mesylate -- administration & dosage
- Kaplan-Meier Estimate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Protein Kinase Inhibitors -- administration & dosage
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- administration & dosage
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.